Trade LFCR stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Lifecore Biomedical, Inc. (LFCR) is trading at US$6.43, down 0.16% today as of Oct 8, 16:00 EDT. The company has a market capitalisation of US$171.85M. Over the past 52 weeks, LFCR has traded between US$3.63 and US$8.98. On Syfe you can trade LFCR with $0 commission and add it to your watchlist.
| Previous close | US$6.44 |
|---|---|
| Market cap | US$171.85M |
| 52-week range | US$3.63 – US$8.98 |
| Volume | 491.94K |
| Exchange | US |
Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. It focuses on selling products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the Ophthalmic, Orthopedic and other markets. The company was founded by Otto Sartorius in 1965 and is headquartered in Chaska, MN.
Year: 1996
Lifecore Biomedical, Inc. (LFCR) stock is trading at US$6.43, -0.16% from the previous close of US$6.44.
The market cap for Lifecore Biomedical, Inc. (LFCR) stock is approximately US$171.85M.
The 52-week high for Lifecore Biomedical, Inc. (LFCR) stock is US$8.98.
The 52-week low for Lifecore Biomedical, Inc. (LFCR) stock is US$3.63.
Lifecore Biomedical, Inc. (LFCR) does not currently pay a dividend.
Stay on top of LFCR
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
